Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

89 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in The Netherlands.
van Zwet AA, de Boer WA, Schneeberger PM, Weel J, Jansz AR, Thijs JC. van Zwet AA, et al. Among authors: de boer wa. Eur J Clin Microbiol Infect Dis. 1996 Nov;15(11):861-4. doi: 10.1007/BF01691216. Eur J Clin Microbiol Infect Dis. 1996. PMID: 8997557
[Antibiotic resistance of Helicobacter pylori: prevalence in one region in the southern Netherlands and implications for treatment].
de Boer EM, Schneeberger PM, de Boer WA. de Boer EM, et al. Among authors: de boer wa. Ned Tijdschr Geneeskd. 2014;158:A7501. Ned Tijdschr Geneeskd. 2014. PMID: 25159698 Dutch.
Good bugs and bad bugs: indications and therapies for Helicobacter pylori eradication.
Kuipers EJ, Janssen MJ, de Boer WA. Kuipers EJ, et al. Among authors: de boer wa. Curr Opin Pharmacol. 2003 Oct;3(5):480-5. doi: 10.1016/s1471-4892(03)00116-4. Curr Opin Pharmacol. 2003. PMID: 14559092 Review.
Does Helicobacter pylori infection influence response rate or speed of symptom control in patients with gastroesophageal reflux disease treated with rabeprazole?
de Boer W, de Wit N, Geldof H, Hazelhoff B, Bergmans P, Smout A, Tytgat G. de Boer W, et al. Among authors: de wit n. Scand J Gastroenterol. 2006 Oct;41(10):1147-54. doi: 10.1080/00365520600741546. Scand J Gastroenterol. 2006. PMID: 16990199
Assessment of Helicobacter pylori vacA and cagA genotypes and host serological response.
Figueiredo C, Quint W, Nouhan N, van den Munckhof H, Herbrink P, Scherpenisse J, de Boer W, Schneeberger P, Perez-Perez G, Blaser MJ, van Doorn LJ. Figueiredo C, et al. Among authors: de boer w. J Clin Microbiol. 2001 Apr;39(4):1339-44. doi: 10.1128/JCM.39.4.1339-1344.2001. J Clin Microbiol. 2001. PMID: 11283053 Free PMC article.
Geographic distribution of vacA allelic types of Helicobacter pylori.
Van Doorn LJ, Figueiredo C, M├ęgraud F, Pena S, Midolo P, Queiroz DM, Carneiro F, Vanderborght B, Pegado MD, Sanna R, De Boer W, Schneeberger PM, Correa P, Ng EK, Atherton J, Blaser MJ, Quint WG. Van Doorn LJ, et al. Among authors: de boer w. Gastroenterology. 1999 Apr;116(4):823-30. doi: 10.1016/s0016-5085(99)70065-x. Gastroenterology. 1999. PMID: 10092304
Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection.
de Boer W, Driessen W, Jansz A, Tytgat G. de Boer W, et al. Lancet. 1995 Apr 1;345(8953):817-20. doi: 10.1016/s0140-6736(95)92962-2. Lancet. 1995. PMID: 7898228 Clinical Trial.
Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori.
van Doorn LJ, Figueiredo C, Sanna R, Plaisier A, Schneeberger P, de Boer W, Quint W. van Doorn LJ, et al. Among authors: de boer w. Gastroenterology. 1998 Jul;115(1):58-66. doi: 10.1016/s0016-5085(98)70365-8. Gastroenterology. 1998. PMID: 9649459
Effectiveness of quadruple therapy using lansoprazole, instead of omeprazole, in curing Helicobacter pylori infection.
de Boer WA, van Etten RJ, Lai JY, Schneeberger PM, van de Wouw BA, Driessen WM. de Boer WA, et al. Helicobacter. 1996 Sep;1(3):145-50. doi: 10.1111/j.1523-5378.1996.tb00028.x. Helicobacter. 1996. PMID: 9398895 Clinical Trial.
Long-term follow-up after cure of Helicobacter pylori infection with 4 days of quadruple therapy.
Lai JY, De Boer WA, Driessen WM, Geuskens LM. Lai JY, et al. Among authors: de boer wa. Aliment Pharmacol Ther. 1996 Aug;10(4):645-50. doi: 10.1046/j.1365-2036.1996.43185000.x. Aliment Pharmacol Ther. 1996. PMID: 8853771 Clinical Trial.
89 results
Jump to page